Trackwise Designs — Fundraising supports EV contract

Trackwise Designs (LN: TWD)

Last close As at 28/03/2024

19.00

−9.00 (−47.37%)

Market capitalisation

7m

More on this equity

Research: TMT

Trackwise Designs — Fundraising supports EV contract

Trackwise Designs has announced a fund-raising programme that will raise up to £7.0m (gross) at 80p/share to help provide the working capital needed to support a previously announced order for improved harness technology (IHT) worth up to £54m from a UK electric vehicle (EV) manufacturer. Management notes that FY21 group revenues are expected to be approximately £8.0m because of weaker demand for its advanced printed circuits boards (PCBs) so we have downgraded our FY21 and FY22 EBITDA estimates by 16% and 25% respectively.

Analyst avatar placeholder

Written by

TMT

Trackwise Designs

Fundraising supports EV contract

Placing, subscription and open offer

Tech hardware & equipment

23 December 2021

Price

92.5p

Market cap

£28m

Net debt (£m) at 31 October 2021 (excluding IFRS 16 lease liabilities and prior to December 2021 fundraising)

2.4

Shares in issue (following first tranche of December fund-raising)

30.2m

Free float

64.1%

Code

TWD

Primary exchange

AIM

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(45.4)

(59.9)

(61.4)

Rel (local)

(45.5)

(61.0)

(66.2)

0

52-week high/low

363.1p

92.5p

Business description

Trackwise Designs is a UK manufacturer of specialist products using printed circuit technology. These include a lightweight replacement for conventional wiring harnesses known as IHT and advanced PCBs: microwave and radio frequency, short flex, flex rigid and rigid multilayer products.

Next event

FY21 results

March 2022

Analysts

Anne Margaret Crow

+44 (0)20 3077 5700

Dan Ridsdale

+44 (0)20 3077 5729

Trackwise Designs is a research client of Edison Investment Research Limited

Trackwise Designs has announced a fund-raising programme that will raise up to £7.0m (gross) at 80p/share to help provide the working capital needed to support a previously announced order for improved harness technology (IHT) worth up to £54m from a UK electric vehicle (EV) manufacturer. Management notes that FY21 group revenues are expected to be approximately £8.0m because of weaker demand for its advanced printed circuits boards (PCBs) so we have downgraded our FY21 and FY22 EBITDA estimates by 16% and 25% respectively.

Year end

Revenue (£m)

EBITDA
(£m)

PBT*
(£m)

EPS*
(p)

DPS
(p)

P/E
(x)

12/19

2.9

0.5

0.1

0.8

0.0

115.6

12/20

6.1

0.8

(0.4)

1.4

0.0

66.1

12/21e

8.0

0.7

(1.0)

(1.2)**

0.0

N/A

12/22e

20.8

3.2

0.4

2.0**

0.0

46.3

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. **After issue of first share tranche.

Investment to support contracted revenues

Trackwise has conditionally raised £6.0m through an oversubscribed placing and subscription at 80p/share. The company is also raising up to a further £1m through an open offer to qualifying shareholders, also at 80p/share. The latest date for applications under the open offer to be received is 4 January 2022.The funds raised will be used for growth working capital and capital expenditure. The fundraising, excluding a first tranche of shares which have already been issued, requires shareholder approval at a general meeting which will be held on 5 January 2022. The fund-raising supports an order worth up to £54m over four years from a UK EV manufacturer. Management expects this programme to start ramping up in H122, backed by purchase orders of £0.4m for Q122 and £2.4m for Q222. IHT for the contract will primarily be manufactured at the new Stonehouse site, which is scheduled to commence production at the end of Q122 and to be fully operational by June 2022.

IHT growth accelerating

For the 10 months ended October 2021, Trackwise generated total revenues of £6.6m (unaudited) compared with £6.1m in the year ended December 2020 (FY20). IHT revenues contributed £1.1m compared with £0.6m in the whole of FY20. EBITDA (adjusted for exceptional items and share-based payments) was £0.9m compared with £0.8m in FY20. The order book at the end of October 2021 was £3.3m, of which £1.3m was for delivery in the remainder of FY21, leading to management guidance of c £8.0m total revenues for FY21.

Valuation: IHT growth potential not fully priced in

Our peer multiples-based analysis shows Trackwise trading on EV/Sales and EV/EBITDA multiples for year 2 that are below the peer average. This suggests that at current levels the potential growth in sales and EBITDA associated with the EV opportunity is not fully priced in.

Changes to estimates

Exhibit 1: Revisions to estimates

£m

2020

2021e

2022e

Actual

Old

New

Change

Old

New

Change

Revenues

6.1

9.0

8.0

-11.1%

22.1

20.8

-5.9%

EBITDA

0.8

0.9

0.7

-16.1%

4.3

3.2

-25.2%

Normalised PBT

(0.4)

(0.7)

(1.0)

36.3%

1.9

0.4

-79.2%

Normalised basic EPS (p)

1.42

(1.0)

(1.2)

29.8%

6.3

2.0*

-67.7%

Net debt/(cash)

(8.8)

2.8

4.6

67.7%

2.3

3.5

50.6%

Source: Company data, Edison Investment Research. Note: *On number of shares after issue of first tranche of shares associated with December 2021 fund-raising.

We have made the following adjustments to our estimates:

The advanced printed circuit board (APCB) order book at the end of October 2021 was £2.7m, including £1.1m for FY21 delivery, and APCB revenues up to the end of October were £5.6m. We therefore reduce our estimate for FY21 APCB revenues from £7.8m to £6.8m and our FY22 estimate from £8.3m to £7.0m. The reduction is attributable to weaker demand from two significant customers, both of which are related to supply chain issues in the wider electronics industry.

The IHT order book at the end of October 2021 was £0.5m, of which £0.1m was for delivery in FY21 and IHT revenues up to the of October 2021 were £1.1m, so we leave our estimate of £1.2m IHT revenues in FY21 unchanged. We also leave our estimate of £13.8m IHT revenues in FY22, of which £13.0m is attributable to the EV OEM, unchanged, while noting upside potential for over £19m of IHT deliveries to the EV OEM during the year. We also note that the contract with the EV OEM provides for penalty payments to Trackwise if the OEM does not take a minimum volume of IHT circuits each year during the duration of the contract. At current prices, this minimum volume represents FY22 revenues significantly greater than £13m.

Gross margin during the 10 months ended October 2021 was only 16%, indicating a further decline from the 29.0% reported in H121, which we understand is attributable to inefficiencies linked to coronavirus-related personnel absences. We therefore cut our FY21 gross margin estimate from 32.4% to 22.8%. As the Stonehouse site will not be fully operational until June 2022, some of the manufacturing steps will be outsourced up to that point, with a negative impact on gross margin. We therefore reduce our FY22 gross margin estimate from 33.0% to 30.7%.

We model the dilutive impact on EPS and positive impact on cash flow of only the first tranche of shares, which has increased the number of shares in issue to 30.2m (and raised £1.1m gross), as these did not need shareholder approval to be issued. Assuming that shareholder approval for the fundraising is obtained, the 7.5m shares issued to satisfy the placing and subscription (which include the first tranche of shares and will potentially raise a total of £6.0m gross) will take the total number of shares in issue to 36.3m, diluting FY22 EPS to 1.7p/share. If the open offer is fully taken up, this will result in the issue of a further 1.3m new shares, taking the total in issue to 37.5m, potentially raising £7.0m gross in total and diluting FY22 EPS to 1.6p/share.

Noting that the company has received a total of £0.6m in R&D tax credits so far this year, we raise our FY21 cash tax estimate from £0.3m to £0.6m.

We have increased FY21 working capital requirements to reflect changes in supplier payment terms and a shift to prepayments, as well as higher levels of holdings of key materials.

We have changed the way we present capital expenditure financed through asset leases and now include that within the capital expenditure total in the cash flow rather than excluding it for clarity.

Valuation

Peer multiples

The share price has dropped sharply from the 145p level immediately prior to the announcement of the fund-raising at 80p/share. Our analysis shows Trackwise’s prospective multiples based on (1) the number of shares once the first tranche associated with the placing and subscription have been issued; (2) the total number of shares in issue assuming that the issue of additional shares associated with the placing and subscription is approved (this includes the first tranche of shares but excludes any shares from the open offer); and (3) the total number of shares if the issue of additional shares is approved and the open offer is fully taken up. This total includes all the new shares associated with the placing and subscription. Looking at the multiples for scenarios (2) and (3) we note that Trackwise is trading on EV/Sales and EV/EBITDA multiples for year 2 that are below the peer average. This suggests that at current levels (92.5p/share), the potential growth in sales and EBITDA associated with the EV opportunity, which our estimates show as contributing to much stronger revenue growth than any of the sample between FY20 and FY22, is not fully priced in. We note that the IHT business has the potential to deliver growth that is faster than the average for our sample not just for the period covered by our estimates, but for at least several years beyond that. The peer multiples-based approach therefore fails to recognise the potential of the IHT activity in the longer term.

Exhibit 2: Peer multiples

Name

Market cap ($m)

EV/Sales 1FY (x)

EV/Sales 2FY (x)

EV/EBITDA 1FY (x)

EV/EBITDA 2FY (x)

P/E
1FY (x)

P/E
2FY (x)

CAGR*

EBITDA margin 1FY

EBITDA margin 2FY

AT & S

1,895

1.4

1.4

5.7

6.0

35.8

21.3

21.9%

24.0%

23.2%

CMK

354

0.7

0.6

8.1

5.5

24.4

11.2

8.9%

8.2%

11.5%

Compeq Manufacturing

1,842

0.9

0.8

5.1

4.6

11.1

9.7

5.2%

17.7%

18.3%

Ibiden

8,092

2.4

2.2

7.7

6.4

21.9

18.2

15.8%

31.1%

34.1%

KCE Electronics

3,183

7.1

6.0

29.3

22.2

43.6

30.8

24.3%

24.1%

27.1%

Meiko Electronics

983

1.2

1.1

8.8

8.1

12.4

10.7

14.6%

13.6%

13.4%

Tripod Technology

2,285

1.0

0.9

5.6

4.8

10.3

9.5

8.8%

17.4%

19.0%

TTM Technologies

1,474

0.8

0.8

6.8

6.3

11.4

10.1

4.1%

12.5%

13.0%

Unimicron Technology

11,557

3.3

2.7

15.3

10.5

27.8

20.8

18.8%

21.5%

26.0%

Zhen Ding Technology

3,325

0.8

0.8

4.8

4.1

10.0

8.7

12.8%

17.6%

18.7%

Mean

2.0

1.7

9.7

7.9

20.9

15.1

18.8%

20.4%

Trackwise Designs after issue of first share tranche (1)

37

2.2

0.9

25.2

5.6

N/A

45.4

85.2%

8.9%

15.4%

Trackwise Designs after issue of shares from placing and subscription (2)

45

2.3

0.9

26.3

5.9

N/A

54.6

85.2%

8.9%

15.4%

Trackwise Designs assuming full uptake of open offer (3)

46

2.4

0.9

26.5

5.9

N/A

56.4

85.2%

8.9%

15.4%

Source: Refinitiv, Edison Investment Research. Note: Prices at 20 December 2021. *CAGR is compound average growth in revenue between year 0 and year 2.

Scenario analysis

Although we do not present detailed estimates for FY23 and beyond, we have created a scenario analysis to indicate what group revenues and profits would look like for different levels of utilisation of the new Stonehouse site. These scenarios assume that gross margins for the APCB and IHT activities remain at FY22 levels, that the incremental indirect costs are £0.1m for each additional £1.0m of IHT revenues and that the capital cost of a second production line at Stonehouse is £8.0m, funded through bank borrowings, though management may opt for another financing mechanism. The scenarios modelled are:

A: FY22 estimates (ie £13.0m IHT revenues attributable to the EV OEM and £0.8m other IHT revenues).

B: £17.0m IHT revenues attributable to the EV OEM, which is towards the upper bound of the range specified in the agreement, and £0.8m other IHT revenues.

C: £17.0m IHT revenues attributable to the EV OEM, which is towards the upper bound of the range specified in the agreement, plus £7.5m revenues attributable to medical customers, which assumes that one of the major medical device OEMs uses IHT across a single catheter model, and £0.3m other IHT revenues.

D: £32.0m IHT revenues, which could be achieved either by supplying circuits to another EV OEM or for several additional catheter models. This level of volume fully utilises the initial production line in the new Stonehouse facility.

E: £54.8m IHT revenues, which could be achieved by supplying circuits to another EV OEM and for multiple catheter models. At this level of volume, a second production line at Stonehouse would be fully utilised as well.

Exhibit 3: Scenario analysis (£m)

Scenario

A

B

C

D

E

IHT revenue

13.8

17.8

24.8

32.0

54.8

Total revenue

20.8

24.8

31.8

39.0

61.8

EBITDA

3.2

4.1

5.8

7.5

12.9

Normalised PBT

0.4

1.3

3.0

4.7

9.4

Normalised PAT

0.6

1.4

2.7

4.1

7.9

Additional capex

0.0

0.0

0.0

0.0

8.0

Source: Edison Investment Research

The current EV customer is adopting a micro-factory model and intends to build two small factories in the United States in addition to its factory in the UK. It is therefore possible that Trackwise may decide to construct an IHT facility close to one of these factories rather than expanding the Stonehouse facility, or to license the technology to a manufacturing partner that already has facilities close to those of the EV OEM.

Exhibit 4: Financial summary

£m

2019

2020

2021e

2022e

31-December

IFRS

IFRS

IFRS

IFRS

INCOME STATEMENT

Revenue

 

 

2.9

6.1

8.0

20.8

Cost of Sales

(1.8)

(4.4)

(6.2)

(14.4)

Gross Profit

1.1

1.7

1.8

6.4

EBITDA

 

 

0.5

0.8

0.7

3.2

Operating Profit (before amort. and excepts.)

 

0.2

(0.2)

(0.6)

0.8

Amortisation of acquired intangibles

0.0

0.0

0.0

0.0

Exceptionals

(0.0)

(0.1)

0.0

0.0

Share-based payments

(0.2)

(0.2)

(0.2)

(0.2)

Reported operating profit

(0.1)

(0.5)

(0.8)

0.6

Net Interest

(0.1)

(0.2)

(0.3)

(0.4)

Exceptionals

0.0

1.1

0.0

0.0

Profit Before Tax (norm)

 

 

0.1

(0.4)

(1.0)

0.4

Profit Before Tax (reported)

 

 

(0.1)

0.4

(1.2)

0.2

Reported tax

0.1

0.8

0.6

0.3

Profit After Tax (norm)

0.1

0.3

(0.4)

0.6

Profit After Tax (reported)

(0.0)

1.2

(0.6)

0.5

Average Number of Shares Outstanding (m)

14.7

20.7

28.6

30.2

EPS - normalised (p)

 

 

0.8

1.4

(1.2)

2.0

EPS - normalised fully diluted (p)

 

 

0.8

1.4

(1.2)

2.0

EPS - basic reported (p)

 

 

(0.3)

6.0

(1.9)

1.6

Dividend (p)

0.0

0.0

0.0

0.0

Revenue growth (%)

(16.2)

108.8

32.1

159.8

Gross Margin (%)

37.9

28.3

22.8

30.7

EBITDA Margin (%)

17.8

12.7

8.9

15.4

Normalised Operating Margin

6.9

N/A

N/A

3.7

BALANCE SHEET

Fixed Assets

 

 

6.8

14.7

24.5

23.7

Intangible Assets

4.3

6.5

7.2

7.8

Tangible Assets

2.5

8.2

17.3

15.9

Investments & other

0.0

0.0

0.0

0.0

Current Assets

 

 

3.1

18.5

13.3

15.5

Stocks

0.6

2.0

3.3

3.4

Debtors

1.7

1.8

3.3

4.2

Cash & cash equivalents

0.6

13.9

5.9

7.1

Other

0.3

0.8

0.8

0.8

Current Liabilities

 

 

(1.4)

(3.0)

(1.5)

(2.2)

Creditors

(1.0)

(2.0)

(0.4)

(1.1)

Tax and social security

0.0

0.0

0.0

0.0

Short term borrowings (including lease liabilities)

(0.3)

(1.1)

(1.1)

(1.1)

Other

0.0

0.0

0.0

0.0

Long Term Liabilities

 

 

(2.5)

(5.3)

(10.7)

(10.7)

Long term borrowings (including lease liabilities)

(1.3)

(4.1)

(9.5)

(9.5)

Other long term liabilities

(1.3)

(1.2)

(1.2)

(1.2)

Net Assets

 

 

6.0

24.9

25.7

26.3

Minority interests

0.0

0.0

0.0

0.0

Shareholders' equity

 

 

6.0

24.9

25.7

26.3

CASH FLOW

Operating Cash Flow

0.5

0.8

0.7

3.2

Working capital

0.1

(0.6)

(4.3)

(0.4)

Exceptional & other

0.0

(0.6)

0.0

0.0

Tax

0.0

0.7

0.6

0.3

Net operating cash flow

 

 

0.6

0.3

(3.0)

3.1

Capex

(2.7)

(3.2)

(11.2)

(1.6)

Acquisitions/disposals

0.0

(1.6)

0.0

0.0

Net interest

(0.1)

(0.2)

(0.3)

(0.4)

Equity financing

0.0

17.3

1.1

0.0

Dividends

0.0

0.0

0.0

0.0

Other

0.2

0.1

0.0

0.0

Net Cash Flow

(2.0)

12.7

(13.4)

1.2

Opening net debt/(cash)

 

 

(2.3)

1.0

(8.8)

4.6

FX

0.0

0.0

0.0

0.0

Other non-cash movements

(1.3)

(2.9)

0.0

0.0

Closing net debt/(cash)

 

 

1.0

(8.8)

4.6

3.5

Lease liabilities

0.7

2.6

8.0

8.0

Closing net debt/(cash) excluding lease liabilities

0.3

(11.3)

(3.3)

(4.5)

Source: Company accounts, Edison Investment Research


General disclaimer and copyright

This report has been commissioned by Trackwise Designs and prepared and issued by Edison, in consideration of a fee payable by Trackwise Designs. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by Trackwise Designs and prepared and issued by Edison, in consideration of a fee payable by Trackwise Designs. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Trackwise Designs

View All

Latest from the TMT sector

View All TMT content

Research: Healthcare

Arovella Therapeutics — Acquiring DKK1 rights

Arovella Therapeutics (formerly SUDA Pharmaceuticals) has announced it has in-licensed the rights to a novel monoclonal antibody that targets the Dickkopf-1 (DKK1) peptide from MD Anderson Cancer Center (for undisclosed upfront and development milestones as well as single digit royalties). DKK1 has been shown to promote tumour metastasis across a variety of tumour types. The company plans to combine the DKK1 targeting technology with its recently acquired invariant natural killer T (iNKT) cell therapy platform and test DKK1-CAR-iNKT cells (under programme name ALA-104) in cancer models in 2022.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free